Supreme Court Issues Stay, At Least Temporarily Blocking Mifepristone Restrictions From Taking Effect
The Supreme Court granted the Department of Justice’s emergency request to temporarily halt lower court rulings that would have reimposed restrictions on mifepristone that the Food and Drug Administration (FDA) had lifted in recent years.
The stay is in place until 11:59 p.m. ET Wednesday. The anti-abortion plaintiffs’ response to the government’s request for a stay is due by noon on Tuesday.
Read more at Talking Points Memo
Alito keeps access to abortion pill unchanged for next five days while Supreme Court reviews emergency appeals
That prompted the Justice Department and Danco, which makes the brand-name version of mifepristone, to turn to the high court for relief. They said that even the 5th Circuit panel’s approach – leaving the drug approved but rolling back expanded access in recent years – would be highly disruptive and could force the company to stop selling and distributing the drug for months.
Read more at Politico
Supreme Court puts temporary hold on ruling that limits abortion drug access
The new case raises different legal issues concerning the FDA’s process for approving drugs, but will nevertheless put to the test the court’s pledge last year that it would leave abortion policy to the states and federal government.
Read more at NBC News
The Supreme Court hits pause on the abortion pills lawsuit
Both Kacsmaryk’s decision and the Fifth Circuit’s are egregiously wrong. They defy longstanding legal principles establishing that judges may not second-guess the FDA’s scientific judgments. And neither court even had jurisdiction to hear this case.
Read more at Vox